NCT00579293 Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer Status COMPLETED Phase N/A
NCT00579163 Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00579072 The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00579007 Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations Status COMPLETED Phase N/A
NCT00578630 Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients Status COMPLETED Phase N/A
NCT00578435 Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis Status COMPLETED Phase PHASE2
NCT00578409 Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data Status COMPLETED Phase N/A
NCT00578240 Molecular Studies and Clinical Correlations in Human Prostatic Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00578162 A Study of Survivorship Service Capacities Among Health Care Agencies in New York City Status COMPLETED Phase N/A
NCT00578123 Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical Prostatectomy Status COMPLETED Phase NA
NCT00578006 Internet-based System for Cancer Patients to Self-report Toxicity Status COMPLETED Phase NA
NCT00577876 Assessment of the Functional Significance of Accessory Pudendal Arteries Status COMPLETED Phase NA
NCT00577811 Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans Status COMPLETED Phase N/A
NCT00577707 Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON) Status COMPLETED Phase PHASE2